IP Library Granted Patent US 12,268,413
Granted Patent B2
US 12,268,413 · App. 18/146,139 · Granted Apr 8, 2025

Recommending transseptal needle curvature based on anatomy

Inventors: Debby Highsmith (Irvine, CA); Joaquin Kurz (Irvine, CA)
Assignee: Biosense Webster (Israel) Ltd.
A61B17/3403A61B34/10A61B34/20A61B2034/102A61B2034/104A61B2034/105A61B2034/2051A61B2034/2063A61B2034/2065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,268,413
App. No.
18/146,139
Granted
Apr 8, 2025
Kind
B2
Abstract

A tool to determine a pre-puncture needle shape to provide a desired approach to a target location based on measured patient anatomy is disclosed herein. Anatomical relationship between an outlet of an access vessel and a desired puncture sight on the interatrial septum is used to determine the pre-puncture needle shape. The tool may be used to provide a recommended preferred needle shape from a collection of predetermined needle shapes (e.g. commercially available needle shapes) and/or recommend a bent shape to which a physician may modify a predetermined needle shape to fit. Additionally, or alternatively, the tool may be used to provide a recommended preferred needle shape to manufacturers to create a bespoke needle shape for a given patient and/or a recommended preferred needle shape for patient cohort having similar anatomy within the cohort.

Claims (43)

1. A system comprising:

a processor; and

non-transitory computer-readable medium with instructions thereon, that when executed by the processor, cause the system to:

determine a curvature of a transseptal needle based at least in part on a spatial relationship between an access vessel and a target puncture location and a predetermined needle shape;

determine a deployed position of the predetermined needle shape such that a proximal point of the predetermined needle shape is positioned at the access vessel and a distal point of the predetermined needle shape is positioned at an interatrial septum; and

determine the curvature using a rotational matrix to move the distal point to the target puncture location while holding the proximal point fixed.

2. The system of claim 1 , the access vessel comprising an inferior vena cava.

3. The system of claim 1 , the access vessel comprising a superior vena cava.

4. The system of claim 1 , the instructions further being configured to cause the system to:

determine the spatial relationship between the access vessel and the target puncture location.

5. The system of claim 1 , the instructions further being configured to cause the system to:

generate an anatomical map, wherein the anatomical map comprises the access vessel approximate a right atrium and at least a portion of an interatrial septum of the right atrium;

identify, based on the anatomical map, a location of the access vessel approximate the right atrium and the target puncture location; and

determine the spatial relationship between the access vessel and the target puncture location.

6. The system of claim 5 , the instructions further being configured to cause the system to:

modify the display of the anatomical map based on intracardiac fluoroscopy and/or ultrasound data.

7. The system of claim 5 , the instructions further being configured to cause the system to:

generate the anatomical map based at least in part on electromagnetic mapping.

8. The system of claim 1 , further comprising:

a display,

the instructions further being configured to cause the system to:

display a recommended curvature of the transseptal needle on the display.

9. The system of claim 1 , the instructions further being configured to cause the system to:

receive an indication of a needle selection of a needle in a catalogue of needles; and

identify the predetermined needle shape based on the indication of the needle selection.

10. The system of claim 9 , the instructions further being configured to cause the system to:

receive a needle identifier from an electrically erasable programmable read-only memory (EEPROM) of a needle in communication with the system; and

determine the indication of needle selection based at least in part on the needle identifier.

11. The system of claim 1 , the instructions further being configured to cause the system to:

select, based at least in part on the curvature of the transseptal needle, a preferred needle shape from a plurality of pre-determined needle shapes.

12. The system of claim 11 , the instructions further being configured to cause the system to:

recommend, to a user of the system, the preferred needle shape.

13. The system of claim 1 , the instructions further being configured to cause the system to:

recommend a transseptal needle design based at least in part on the curvature.

14. A method for transseptal puncture, the method comprising:

identifying a first location on an anatomical map of a patient, at an outlet of an inferior vena cava;

identifying a second location, on the anatomical map, at a desired puncture site on a fossa ovalis;

extrapolating a curve between the first location and the second location;

determining a deployed position of a predetermined needle shape such that a proximal point of the predetermined needle shape is positioned at the first location and a distal point of the predetermined needle shape is positioned at an interatrial septum;

determining a curvature of a needle shape template based at least in part on the extrapolated curve and using a rotational matrix to move the distal point to the desired puncture site while holding the proximal point fixed; and

providing, on a display, the needle shape template.

15. The method of claim 14 , further comprising:

recommending the predetermined needle shape.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2023
From: HIGHSMITH, DEBBY; KURZ, JOAQUIN
To: BIOSENSE WEBSTER (ISRAEL) LTD.
Reel/Frame 064969/0144 →
Continuity (1)
Related Publication 20240206906A1 · Jun 27, 2024
References Cited (47)
US 5391199A · Ben-Haim · 1995 [cited by applicant]
US 5443489A · Ben-Haim · 1995 [cited by applicant]
US 5462545A · Wang et al. · 1995 [cited by applicant]
US 5558091A · Acker et al. · 1996 [cited by applicant]
US 5807350A · Diaz · 1998 [cited by applicant]
US 6172499B1 · Ashe · 2001 [cited by applicant]
US 6239724B1 · Boron et al. · 2001 [cited by applicant]
US 6332089B1 · Acker et al. · 2001 [cited by applicant]
US 6484118B1 · Govari · 2002 [cited by applicant]
US 6618612B1 · Acker et al. · 2003 [cited by applicant]
US 6690963B2 · Ben-Haim et al. · 2004 [cited by applicant]
US 6788967B2 · Ben-Haim et al. · 2004 [cited by applicant]
US 6892091B1 · Ben-Haim et al. · 2005 [cited by applicant]
US 7536218B2 · Govari et al. · 2009 [cited by applicant]
US 7756576B2 · Levin · 2010 [cited by applicant]
US 7848787B2 · Osadchy · 2010 [cited by applicant]
US 7869865B2 · Govari et al. · 2011 [cited by applicant]
US 8235986B2 · Kulesa et al. · 2012 [cited by applicant]
US 8456182B2 · Bar-Tel et al. · 2013 [cited by applicant]
US 9326813B2 · Pike, Jr. et al. · 2016 [cited by applicant]
US 10065032B2 · Ollivier · 2018 [cited by applicant]
US 10194937B2 · Schultz · 2019 [cited by applicant]
US 10413707B2 · Douglas · 2019 [cited by applicant]
US 20030018246A1 · Govari et al. · 2003 [cited by applicant]
US 20040082860A1 · Haissaguerre · 2004 [cited by applicant]
US 20040220471A1 · Schwartz · 2004 [cited by applicant]
US 20050055089A1 · Macoviak et al. · 2005 [cited by applicant]
US 20120232546A1 · Mirza et al. · 2012 [cited by applicant]
US 20150182255A1 · Shivkumar · 2015 [cited by examiner]
US 20170014113A1 · Ma · 2017 [cited by examiner]
US 20180154114A1 · Tang et al. · 2018 [cited by applicant]
US 20190000551A1 · Sone et al. · 2019 [cited by applicant]
US 20190083187A1 · Danitz · 2019 [cited by examiner]
US 20200261158A1 · Ward et al. · 2020 [cited by applicant]
US 20210334999A1 · Lee · 2021 [cited by examiner]
US 20210401483A1 · Highsmith · 2021 [cited by applicant]
US 20220133261A1 · Urman et al. · 2022 [cited by applicant]
CN 114748136A · 2022 [cited by applicant]
EP 1034738A1 · 2000 [cited by applicant]
EP 1325708A2 · 2003 [cited by applicant]
EP 1472976A1 · 2004 [cited by applicant]
WO WO9605768A1 · 1996 [cited by applicant]
WO WO9939624A1 · 1999 [cited by applicant]
WO WO0180922A2 · 2001 [cited by applicant]
WO WO02071955A2 · 2002 [cited by applicant]
WO WO2014162470 · 2014 [cited by examiner]
Extended European Search Report and Opinion dated May 28, 2024, from corresponding European Application No. 23219679.0. [cited by applicant]